CD44 and breast carcinoma: These, together with the dynamic process of spontaneous conversion of non-CSC CD44-/CD24- cells and CSC differentiation, indicate that the spontaneous conversion of CD44-/CD24- cells helps maintain the CSC pool size, contributing to the delayed distant metastasis and worse prognosis in breast cancer patients.